Conference Coverage

Increased risk of second cancers in mycosis fungoides

LA JOLLA, CALIF. – Researchers found the risk of second malignancy was highest among MF patients aged 30 to 50 years and patients who had tumor...

Daily News Podcast

Automated office BP readings

Phase 3 studies of antiamyloid Alzheimer’s drug crenezumab are stopped.

Conference Coverage

Combo emerges as bridge to transplant in rel/ref PTCL

LA JOLLA, CALIF. – Researchers plan to expand the duvelisib plus romidepsin arm to better understand the occurrence of transaminitis and assess...